Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-245652
Filing Date
2024-10-28
Accepted
2024-10-28 17:20:58
Documents
8
Period of Report
2024-11-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d898375ddef14a.htm DEF 14A 371229
2 GRAPHIC g898375g01n01.jpg GRAPHIC 415287
3 GRAPHIC g898375g02n02.jpg GRAPHIC 299113
4 GRAPHIC g898375g04a04.jpg GRAPHIC 45335
5 GRAPHIC g898375g05k87.jpg GRAPHIC 46132
6 GRAPHIC g898375g38t37.jpg GRAPHIC 18190
7 GRAPHIC g898375g85b95.jpg GRAPHIC 57897
8 GRAPHIC g898375g99d47.jpg GRAPHIC 41477
  Complete submission text file 0001193125-24-245652.txt   1645103
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32979 | Film No.: 241401918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)